4.3.2.1	1-ethyl-3-(3-diethylaminopropyl)carbodiimide	at pH 6	95613	
4.3.2.1	acetylenedicarboxylate	-	20098	
4.3.2.1	Arg	noncompetitive versus argininosuccinate	367	
4.3.2.1	argininosuccinate	0.3 mM inhibits the reaction by 97%	1461	
4.3.2.1	bromomesaconic acid	argininosuccinate completely protects, Lys51 has an essential role in binding of argininosuccinate and consequently is essential in catalysis; inactivation follows pseudo-first-order kinetics	43885	
4.3.2.1	citrulline	competitive versus Arg and noncompetitive versus argininosuccinate and fumarate	1464	
4.3.2.1	citrulline	noncompetitive vs. fumarate and arginine	1464	
4.3.2.1	D-glucose	12.5 mM glucose decreases activity of ASL by 20%, 25 mM glucose by 50%	35	
4.3.2.1	diethyl dicarbonate	-	463	
4.3.2.1	diethyl dicarbonate	modification of an essential His	463	
4.3.2.1	difluorofumarate	pseudo-first-order process	29942	
4.3.2.1	fumarate	noncompetitive versus argininosuccinate	170	
4.3.2.1	fumarate	a potential feedback mechanism is proposed, wherein the Cys441 is covalently modified to S-(2-succinyl) cysteine by one of the products, fumarate	170	
4.3.2.1	monofluorofumarate	reversible, pseudo-first-order process	31052	
4.3.2.1	additional information	the antibody of the liver enzyme is an effective inhibitor of brain enzyme	2	
4.3.2.1	additional information	mRNA expression and activity of liver argininosuccinate lyase decrease with age	2	
4.3.2.1	additional information	acetylation at Lys288 or Lys69 decreases activity of ASL	2	
4.3.2.1	N3-(L-1-carboxy-2-nitroethyl)-L-arginine	-	94412	
4.3.2.1	succinate	dead-end inhibitor	58	
4.3.2.1	succinate	noncompetitive vs. fumarate and arginine	58	
4.3.2.1	Urea	competitive	116